Analysis of Genomic Alterations Associated with Recurrence in Early Stage HER2-Positive Breast Cancer

Analysis of Genomic Alterations Associated with Recurrence in Early Stage HER2-Positive Breast Cancer

We aimed to compare gene expression in primary tumors of patients with recurrence and nonrecurrence to gain insight into the biology of high-risk HER2-positive early breast cancer. Patients who underwent curative resection and received adjuvant trastuzumab for HER2-positive early breast cancer were...

Full description

Bibliographic Details
Main Authors: Yong-Seok Kim, Der Sheng Sun, Juneyoung Ahn, Yongseon Kim, Jung-Sook Yoon, Hye Sung Won
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Cancers
Subjects:
breast cancer
human epidermal growth factor receptor 2
recurrence
tumor inflammation signature
Online Access:https://www.mdpi.com/2072-6694/14/15/3650

Similar Items

Similar Items